Assessment of illness severity in community acquired pneumonia: a useful new prediction tool?

Woodhead, M.
May 2003
Thorax;May2003, Vol. 58 Issue 5, p371
Academic Journal
Editorial. Focuses on the use of Confusion Blood Urea Respiratory Rate and Blood Pressure (CURB)-65 severity prediction tool in assessing illness severity in community acquired pneumonia. Identification of the most important prognostic factors associated with the mortality of hospitalized adult patients from primary care based healthcare systems; Calculation of the CURB severity score.


Related Articles

  • Bronchiolitis obliterans and organising pneumonia caused by carbamazepine and mimicking community acquired pneumonia. R Banka // Postgraduate Medical Journal;Oct2002, Vol. 78 Issue 924, p621 

    Bronchiolitis obliterans and organising pneumonia (BOOP) presents with fever, dyspnoea, and other features that may be mistaken for pneumonia. Treatment is, however, very different, requiring corticosteroids. A man was admitted as an emergency with fever, dyspnoea, and non-productive cough. The...

  • COPD Increases Risk for Post-Op Pneumonia.  // RT: The Journal for Respiratory Care Practitioners;May2010, Vol. 23 Issue 5, p35 

    The article reports that 15 percent of chronic obstructive pulmonary disease (COPD) patients developed postoperative pneumonia based on the results of a review published in the "European Journal of Cardio-Thoracic Surgery."

  • Benzodiazepines and pneumonia or aspiration pneumonitis. Campbell-Taylor, Irene // Thorax;Jun2013, Vol. 68 Issue 6, p591 

    The article focuses on the effect on benzodiazepines on patients with diabetes, Parkinson disease and Chronic Obstructive Pulmonary Disease (COPD) while treating for pneumonia.

  • Doubt over steroids in COPD. Praities, Nigel // Pulse;12/3/2008, Vol. 68 Issue 42, p10 

    The article reports on the study on the routine use of inhaled steroids in patients with Chronic Obstructive Pulmonary Disease (COPD). It shows that steroids had no significant effect on all-cause mortality, but increased the risk of pneumonia by 34%. Furthermore, researchers warned that...

  • Number needed to treat in COPD: exacerbations versus pneumonias. Keene, Oliver N.; Anzueto, Antonio; Ferguson, Gary T.; Calverley, Peter M. A.; Suissa, Samy // Thorax;Sep2013, Vol. 68 Issue 9, p882 

    A letter to the editor is presented in response to the article "Number Needed to Treat in COPD: Exacerbations Versus Pneumonias" by S. Suissa and colleagues in the 2013 issue.

  • Corrections.  // Thorax;Feb2015, Vol. 70 Issue 2, p182 

    A correction to the article "Stratifying pneumonic episodes and acute exacerbations in COPD patients: A continuum or discrete phenomena?" that was published in a 2014 issue is presented.

  • Pneumonia complications with combination inhalers in COPD.  // Reactions Weekly;6/8/2013, Issue 1456, p3 

    The article focuses on a cohort study revealing that the risk of pneumonia that complicates chronic obstructive pulmonary disease is 73% higher in patients treated with fluticasone and salmeterol combination inhaler compare to those treated with budesonide and formoterol combination inhaler.

  • Fluticasone/salmeterol is associated with a higher risk of pneumonia and pneumonia related events in comparison with budesonide/formoterol in patients with COPD. Jabbar, Avais // Thorax;Nov2013, Vol. 68 Issue 11, p996 

    In this article, the author reflects on a PATHOS study related to the association of combined drug treatment process with fluticasone and salmeterol with higher risks of pneumonia and compares the impact of budesonide and formoterol on patients with chronic obstructive pulmonary disease (COPD)...

  • Inhaled fluticasone and budesonide increased the risk of serious pneumonia in COPD. White, Patrick // Evidence Based Medicine;Jun2014, Vol. 19 Issue 3, p116 

    The author reflects on a study "Inhaled corticosteroids in COPD and the risk of serious pneumonia" by S. Suissa and colleagues, that was published in the 2013 issues of the journal "Thorax." Topics discussed include the role of high-dose inhaled corticosteroids (ICS) to reduce exacerbations in...


Read the Article


Sign out of this library

Other Topics